Revenue Summary of UniPharma Co., Ltd.

UniPharma Co., Ltd.'s latest annual revenue in 2023 was 103.22 Million TWD , down -19.43% from previous year.
UniPharma Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 23.49 Million TWD , down 0.0% from previous quarter.
UniPharma Co., Ltd. reported a annual revenue of 128.1 Million TWD in annual revenue 2022, up 21.56% from previous year.
UniPharma Co., Ltd. reported a annual revenue of 105.38 Million TWD in annual revenue 2021, down -23.98% from previous year.
UniPharma Co., Ltd. reported a quarterly revenue of 23.49 Million TWD for 2024 Q2, down 0.0% from previous quarter.
UniPharma Co., Ltd. reported a quarterly revenue of 26.28 Million TWD for 2023 Q3, up 3.79% from previous quarter.

Annual Revenue Chart of UniPharma Co., Ltd. (2023 - 2019)

Name	Revenue	Revenue Difference
Allied Biotech Corporation	720.43 Million TWD	85.672%
GeneFerm Biotechnology Co., Ltd.	793.77 Million TWD	86.996%
Easywell Biomedicals, Inc.	271.62 Million TWD	61.999%
TTY Biopharm Company Limited	5.5 Billion TWD	98.125%
Synmosa Biopharma Corporation	5.14 Billion TWD	97.992%
Orient EuroPharma Co., Ltd.	4.59 Billion TWD	97.752%
Center Laboratories, Inc.	1.39 Billion TWD	92.595%
Tien Liang BioTech Co., Ltd.	459.99 Million TWD	77.56%
Orient Pharma Co., Ltd.	889.91 Million TWD	88.401%
InnoPharmax Inc.	46.07 Million TWD	-124.04%
Johnson Chemical Pharmaceutical Works Co., Ltd.	606.71 Million TWD	82.987%
Excelsior Biopharma Inc.	771.56 Million TWD	86.622%
DV Biomed Co., Ltd.	1.53 Billion TWD	93.29%
Foresee Pharmaceuticals Co., Ltd.	195.03 Million TWD	47.076%
Handa Pharmaceuticals, Inc.	1.1 Billion TWD	90.67%
Anxo Pharmaceutical Co., Ltd.	939.94 Million TWD	89.018%
Alar Pharmaceuticals Inc.	469.27 Million TWD	78.004%
Winston Medical Supply Co., Ltd.	709.07 Million TWD	85.443%
Mercury Biopharmaceutical Corporation	1.03 Million TWD	-9892.449%
Bioray Biotech Co., Ltd	191.83 Million TWD	46.191%
TSH Biopharm Corporation Limited	810.91 Million TWD	87.271%